Green Thumb Industries Inc. (GTBIF) Financials

GTBIF Assets vs Liabilities

DateAssetsLiabilities
March 31, 2026 2.8 billion 934.6 million
Dec. 31, 2025 2.8 billion 879.4 million
Sept. 30, 2025 2.6 billion 804.3 million
June 30, 2025 2.5 billion 748.8 million

GTBIF Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 56.9 million 10.5 million
Dec. 31, 2025 75.5 million 11.0 million
Sept. 30, 2025 56.6 million 11.7 million
June 30, 2025 37.4 million 12.0 million

GTBIF Net Income

Graph available only for paid members. Upgrade to see it.
DateNet Income
March 31, 2026 15.4 million
Dec. 31, 2025 84.8 million
Sept. 30, 2025 21.8 million
June 30, 2025 732000

GTBIF Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 346.2 million 519.8 million -
Dec. 31, 2025 274.3 million 226.0 million 254.6 million
Sept. 30, 2025 235.4 million 484.1 million -
June 30, 2025 176.9 million 234.1 million 272.8 million

GTBIF Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 ?
Dec. 31, 2025 ?
Sept. 30, 2025 ?
June 30, 2025 ?

GTBIF Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 18.9 million - 102.9 million -
Dec. 31, 2025 14.7 million - - -
Sept. 30, 2025 17.5 million - 107.3 million -
June 30, 2025 19.0 million - 106.8 million -

GTBIF Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 300.2 million 156.5 million
Dec. 31, 2025 311.1 million 169.8 million
Sept. 30, 2025 291.4 million 147.3 million
June 30, 2025 293.3 million 147.0 million

GTBIF Revenue by Segment

Graph available only for paid members. Upgrade to see it.

GTBIF

Price: $7.95

52 week price:
4.80
10.43

Payout Ratio Range:
-53943.03%
979.25%

Earnings Per Share: 0.17 USD

P/E Ratio: 38.24

Exchange: OQX

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 658300

Market Capitalization: 1.8 billion

Links: